How would you manage a HR+/HER2+ breast cancer patient with no response during neoadjuvant TCHP?   

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at Alvin & Lois Lapidus Cancer Institute Northwest Hospital
Thank you for your response. Off study - would yo...
Medical Oncologist at Warren Alpert Medical School of Brown University
We don't know the benefit of subsequent neratinib ...
Sign in or Register to read more